Fire & Flower: A Weed Stock With a Better Business Model Than Canopy Growth?
The Company has strong retail operations capabilities – being Canada’s largest multi-brand cannabis retailer – while its proprietary Hifyre digital platform & analytics connects consumers with cannabis products, delivers high-margin recurring subscription revenues, and adds value to acquisitions.
“If you are a smaller U.S. MSO trying to grow aggressively and are given a bazooka to go out and compete with great tools like Hifyre technology and Spark Perks™ loyalty program. What would that be worth to you? Knowing there are bigger MSOs out there and lots of consolidation going on. If you were given a head start and a path to acquisition by Fire & Flower. That is a significant event.” – Trevor Fencott, Fire & Flower Holdings Corp CEO
Through its strategic investment with Alimentation Couche-Tard (OTCMKTS: ANCTF) (OTCMKTS: ANCUF), the Company has set its sights on U.S. expansion. The company has applied to list on the NASDAQ stock exchange and officially entered the U.S. cannabis market through a licensing partnership with American Acres with an acquisition option.
Watch the full interview with Fire & flower to see all the company’s latest developments and why we are following the company with interest.
Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.
Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.
Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.